Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-055720
Filing Date
2025-06-03
Accepted
2025-06-03 07:45:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2516962d1_defa14a.htm DEFA14A 32896
  Complete submission text file 0001104659-25-055720.txt   34034
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40969 | Film No.: 251017179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)